Cargando…

P62 USE OF ANTIVIRAL FOR PAUCISINTOMATIC COVID-19 INFECTION IN MULTIPLE MYELOMA PATIENTS UNDERGOING TREATMENT

Detalles Bibliográficos
Autores principales: Annibali, O., F, Fazio, M, Di Cecca, C, Liberatore, F, Pisani, L, De Padua, V, Tomarchio, R, Poggiali, F, Fioritoni, MT, Tafuri, F, Viola, G, Montanaro, M, Passucci, S, Pulini, MT, Petrucci, L, Rigacci
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171582/
http://dx.doi.org/10.1097/01.HS9.0000936376.38414.ca
_version_ 1785039450553712640
author Annibali, O.
F, Fazio
M, Di Cecca
C, Liberatore
F, Pisani
L, De Padua
V, Tomarchio
R, Poggiali
F, Fioritoni
MT, Tafuri
F, Viola
G, Montanaro
M, Passucci
S, Pulini
MT, Petrucci
L, Rigacci
author_facet Annibali, O.
F, Fazio
M, Di Cecca
C, Liberatore
F, Pisani
L, De Padua
V, Tomarchio
R, Poggiali
F, Fioritoni
MT, Tafuri
F, Viola
G, Montanaro
M, Passucci
S, Pulini
MT, Petrucci
L, Rigacci
author_sort Annibali, O.
collection PubMed
description
format Online
Article
Text
id pubmed-10171582
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-101715822023-05-11 P62 USE OF ANTIVIRAL FOR PAUCISINTOMATIC COVID-19 INFECTION IN MULTIPLE MYELOMA PATIENTS UNDERGOING TREATMENT Annibali, O. F, Fazio M, Di Cecca C, Liberatore F, Pisani L, De Padua V, Tomarchio R, Poggiali F, Fioritoni MT, Tafuri F, Viola G, Montanaro M, Passucci S, Pulini MT, Petrucci L, Rigacci Hemasphere Poster Lippincott Williams & Wilkins 2023-05-09 /pmc/articles/PMC10171582/ http://dx.doi.org/10.1097/01.HS9.0000936376.38414.ca Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Poster
Annibali, O.
F, Fazio
M, Di Cecca
C, Liberatore
F, Pisani
L, De Padua
V, Tomarchio
R, Poggiali
F, Fioritoni
MT, Tafuri
F, Viola
G, Montanaro
M, Passucci
S, Pulini
MT, Petrucci
L, Rigacci
P62 USE OF ANTIVIRAL FOR PAUCISINTOMATIC COVID-19 INFECTION IN MULTIPLE MYELOMA PATIENTS UNDERGOING TREATMENT
title P62 USE OF ANTIVIRAL FOR PAUCISINTOMATIC COVID-19 INFECTION IN MULTIPLE MYELOMA PATIENTS UNDERGOING TREATMENT
title_full P62 USE OF ANTIVIRAL FOR PAUCISINTOMATIC COVID-19 INFECTION IN MULTIPLE MYELOMA PATIENTS UNDERGOING TREATMENT
title_fullStr P62 USE OF ANTIVIRAL FOR PAUCISINTOMATIC COVID-19 INFECTION IN MULTIPLE MYELOMA PATIENTS UNDERGOING TREATMENT
title_full_unstemmed P62 USE OF ANTIVIRAL FOR PAUCISINTOMATIC COVID-19 INFECTION IN MULTIPLE MYELOMA PATIENTS UNDERGOING TREATMENT
title_short P62 USE OF ANTIVIRAL FOR PAUCISINTOMATIC COVID-19 INFECTION IN MULTIPLE MYELOMA PATIENTS UNDERGOING TREATMENT
title_sort p62 use of antiviral for paucisintomatic covid-19 infection in multiple myeloma patients undergoing treatment
topic Poster
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171582/
http://dx.doi.org/10.1097/01.HS9.0000936376.38414.ca
work_keys_str_mv AT annibalio p62useofantiviralforpaucisintomaticcovid19infectioninmultiplemyelomapatientsundergoingtreatment
AT ffazio p62useofantiviralforpaucisintomaticcovid19infectioninmultiplemyelomapatientsundergoingtreatment
AT mdicecca p62useofantiviralforpaucisintomaticcovid19infectioninmultiplemyelomapatientsundergoingtreatment
AT cliberatore p62useofantiviralforpaucisintomaticcovid19infectioninmultiplemyelomapatientsundergoingtreatment
AT fpisani p62useofantiviralforpaucisintomaticcovid19infectioninmultiplemyelomapatientsundergoingtreatment
AT ldepadua p62useofantiviralforpaucisintomaticcovid19infectioninmultiplemyelomapatientsundergoingtreatment
AT vtomarchio p62useofantiviralforpaucisintomaticcovid19infectioninmultiplemyelomapatientsundergoingtreatment
AT rpoggiali p62useofantiviralforpaucisintomaticcovid19infectioninmultiplemyelomapatientsundergoingtreatment
AT ffioritoni p62useofantiviralforpaucisintomaticcovid19infectioninmultiplemyelomapatientsundergoingtreatment
AT mttafuri p62useofantiviralforpaucisintomaticcovid19infectioninmultiplemyelomapatientsundergoingtreatment
AT fviola p62useofantiviralforpaucisintomaticcovid19infectioninmultiplemyelomapatientsundergoingtreatment
AT gmontanaro p62useofantiviralforpaucisintomaticcovid19infectioninmultiplemyelomapatientsundergoingtreatment
AT mpassucci p62useofantiviralforpaucisintomaticcovid19infectioninmultiplemyelomapatientsundergoingtreatment
AT spulini p62useofantiviralforpaucisintomaticcovid19infectioninmultiplemyelomapatientsundergoingtreatment
AT mtpetrucci p62useofantiviralforpaucisintomaticcovid19infectioninmultiplemyelomapatientsundergoingtreatment
AT lrigacci p62useofantiviralforpaucisintomaticcovid19infectioninmultiplemyelomapatientsundergoingtreatment